col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


34 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Controlled Release
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jan―24 Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival Sabrina Mendes, Lays Cordeiro Guimarães, Leonardo Camilo de Oliveira, Pedro Augusto Carvalho Costa, Natália Jordana Alves da Silva, Gabriel Silva Alves Pessim Pereira, et al. (+7)
2 [GO] 2024―Dez―16 Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine Guibin Lin, Yan-Lai Tang, Zhengqiang Fu, Runjun Chen, Yan Liu, Zhanyan Liu, et al. (+4)
3 [GO] 2024―Nov―17 Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability Gaurav K. Gulati, Adrian C. Simpson, Zachary MacMillen, Kyle Krieger, Shibbu Sharma, Jesse H. Erasmus, et al. (+4)
4 [GO] 2024―Jan―20 Protein subunit vaccines: Promising frontiers against COVID-19 Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, Subhash C. Chauhan, Nikita Tiwari, Somanshi Shukla, et al. (+4)
5 [GO] 2024―Jan―11 An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants Lei Huang, Fanfan Zhao, Muye He, Yi Fang, Xiaoping Ma, Shuaiyao Lu, et al. (+13)
6 [GO] 2023―Nov―22 Nanomedicine approaches against SARS-CoV-2 and variants Han Zhang, Yanbin Liu, Zhuang Liu
7 [GO] 2023―Nov―16 Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system Philipp Reus, Hadar Guthmann, Nadja Uhlig, Majd Agbaria, Leila Issmail, Valentina Eberlein, et al. (+12)
8 [GO] 2023―Sep―09 Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine Cian M. McCrudden, Lindsey Bennie, Philip Chambers, Jordan Wilson, Megan Kerr, Monika Ziminska, et al. (+7)
9 [GO] 2023―Jul―05 Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, Selma Zargari, Farzaneh Alizadeh, Mahyar Dorrigiv, et al. (+12)
10 [GO] 2023―Mai―31 Plant-derived single domain COVID-19 antibodies Andrew M. Shen, Obeid M. Malekshah, Natalia Pogrebnyak, Tamara Minko
11 [GO] 2023―Mai―15 Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases Shahin Homaeigohar, Xuan Liu, Mady Elbahri
12 [GO] 2023―Apr―30 Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation Han Cong Seow, Jian-Piao Cai, Harry Weijie Pan, Cuiting Luo, Kun Wen, Jianwen Situ, et al. (+5)
13 [GO] 2023―Feb―17 Recent advances in respiratory immunization: A focus on COVID-19 vaccines Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du, Xun Sun
14 [GO] 2023―Feb―08 Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19 Yu Wen, Ru-Yan Zhang, Jian Wang, Shi-Hao Zhou, Xiao-Qian Peng, Dong Ding, et al. (+3)
15 [GO] 2023―Jan―13 Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine) Yaelle Bavli, Bing-Mae Chen, Guy Gross, Alon Hershko, Keren Turjeman, Steve Roffler, Yechezkel Barenholz
16 [GO] 2022―Mai―20 Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine Alexandra Atalis, Mark C. Keenum, Bhawana Pandey, Alexander Beach, Pallab Pradhan, Casey Vantucci, et al. (+10)
17 [GO] 2022―Apr―27 COVID-19 inflammation and implications in drug delivery Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, Wei He
18 [GO] 2022―Mrz―30 Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes Domizia Baldassi, Shubhankar Ambike, Martin Feuerherd, Cho-Chin Cheng, David J. Peeler, Daniel P. Feldmann, et al. (+10)
19 [GO] 2022―Mrz―28 Can pulmonary RNA delivery improve our pandemic preparedness? Olivia M. Merkel
20 [GO] 2022―Mrz―21 mRNA vaccines for COVID-19 and diverse diseases Abid Hussain, Haiyin Yang, Mengjie Zhang, Qing Liu, Ghallab Alotaibi, Muhammad Irfan, et al. (+5)
21 [GO] 2022―Feb―03 Strategies for fighting pandemic virus infections: Integration of virology and drug delivery Takashi Nakamura, Norikazu Isoda, Yoshihiro Sakoda, Hideyoshi Harashima
22 [GO] 2021―Nov―20 Pulmonary surfactant as a versatile biomaterial to fight COVID-19 Lore Herman, Stefaan C. De Smedt, Koen Raemdonck
23 [GO] 2021―Aug―31 Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2 Siya Kamat, Madhuree Kumari, C. Jayabaskaran
24 [GO] 2021―Jul―20 Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2 Salma N. Tammam, Sara El Safy, Shahenda Ramadan, Sita Arjune, Eva Krakor, Sanjay Mathur
25 [GO] 2021―Jun―25 Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies Akbar Hasanzadeh, Masoomeh Alamdaran, Sepideh Ahmadi, Helena Nourizadeh, Mohammad Aref Bagherzadeh, Mirza Ali Mofazzal Jahromi, et al. (+3)
26 [GO] 2021―Jun―24 Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation Paul-Michel Mertes, Olivier Collange, Pierre Coliat, Mainak Banerjee, Marie-Charlotte Diringer, Anne Roche, et al. (+21)
27 [GO] 2021―Jun―03 Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection Yuxuan Fu, Sidong Xiong
28 [GO] 2021―Mai―21 The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2 Hai Huang, Caili Zhang, Shuping Yang, Wen Xiao, Qian Zheng, Xiangrong Song
29 [GO] 2021―Mrz―30 The dawn of mRNA vaccines: The COVID-19 case Rein Verbeke, Ine Lentacker, Stefaan C. De Smedt, Heleen Dewitte
30 [GO] 2020―Dez―20 Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2 Kyung Soo Park, Joseph D. Bazzill, Sejin Son, Jutaek Nam, Seung Won Shin, Lukasz J. Ochyl, et al. (+9)
31 [GO] 2020―Dez―02 Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19 Samuel K. Lai, Morgan D. McSweeney, Raymond J. Pickles
32 [GO] 2020―Okt―07 Ivermectin: An award-winning drug with antiviral expectations against COVID-19 Fabio Rocha Formiga, Roger Leblanc, Juliana de Souza Rebouças, Leonardo Paiva Farias, Ronaldo Nascimento de Oliveira, Lindomar Pena
33 [GO] 2020―Aug―31 Nanotheranostics against COVID-19: From multivalent to immune-targeted materials Parichehr Hassanzadeh
34 [GO] 2020―Jul―03 Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? (*) Maurizio Muraca, Augusto Pessina, Michela Pozzobon, Massimo Dominici, Umberto Galderisi, Lorenza Lazzari, et al. (+4)
 [1] 

34 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec